Application 076606

Type: ANDA
Sponsor: SUN PHARM INDS LTD

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	GABAPENTIN	GABAPENTIN	CAPSULE;ORAL	100MG	No	No
002	GABAPENTIN	GABAPENTIN	CAPSULE;ORAL	300MG	No	No
003	GABAPENTIN	GABAPENTIN	CAPSULE;ORAL	400MG	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A076606-001	GABAPENTIN	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07
A076606-002	GABAPENTIN	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07
A076606-003	GABAPENTIN	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 132 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076606-002	GABAPENTIN	300MG	CAPSULE / ORAL	2005-10-07	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076606-003	GABAPENTIN	400MG	CAPSULE / ORAL	2005-10-07	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076606-001	GABAPENTIN	100MG	CAPSULE / ORAL	2005-10-07	`79d66fd596c7…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 7 of 20 · 394 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Gabapentin	GABAPENTIN	Strides Pharma Science Limited	798575b9-ddfa-4915-9574-626abbaf025f	2026-04-04	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	75caca13-1432-4c0d-8d45-f029b0b2d417	2026-03-31	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	56378630-e7a7-4981-8212-8ea703a433d8	2026-03-31	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
GABAPENTIN	GABAPENTIN	ST. MARY'S MEDICAL PARK PHARMACY	4ddc1342-5c83-f562-e063-6294a90a29ba	2026-03-25	Warnings, Adverse reactions	Name fallback brand name: GABAPENTIN generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Advanced Rx of Tennessee, LLC	afc83432-8fce-6d2a-e053-2a95a90ae73f	2026-03-19	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	PD-Rx Pharmaceuticals, Inc.	81774da8-cb1d-4c7d-8550-35396850d5ff	2026-03-18	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	912d8697-b466-48dc-88d3-d2ba90e76644	2026-03-12	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Radha Pharmaceuticals, Inc.	1045db4e-4c76-4a0d-bf12-019bd96a8f59	2026-03-11	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Direct_Rx	0b286fd1-8179-d87a-e063-6294a90a2f23	2026-03-05	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	American Health Packaging	e00f5048-1a06-44f4-b244-aa2755f4be22	2026-03-02	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Solco Healthcare US, LLC	360d953b-4313-45ae-b933-296547d4577d	2026-02-28	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	A-S Medication Solutions	54c09aa5-6724-480a-a115-c88484e39e93	2026-02-24	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Advagen Pharma Ltd	401b30fc-e143-4906-aae1-e5b5c190d4a8	2026-02-24	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	Advagen Pharma Ltd	bfee67dc-d2b1-4a00-92d9-a42be3189c74	2026-02-24	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	ScieGen Pharmaceuticals, Inc.	5ab9c18b-9568-4dcb-90b0-252aef8f8dc2	2026-02-20	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
GABAPENTIN	GABAPENTIN	PD-Rx Pharmaceuticals, Inc.	9814b76c-87c6-4746-b712-3269352a901b	2026-02-16	Warnings, Adverse reactions	Name fallback brand name: GABAPENTIN generic name: GABAPENTIN
GABAPENTIN	GABAPENTIN	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	d8daa30f-1cb3-46aa-9b68-d9aa5b0a2105	2026-02-12	Warnings, Adverse reactions	Name fallback brand name: GABAPENTIN generic name: GABAPENTIN
Gabapentin	GABAPENTIN	A-S Medication Solutions	c979f80b-d4b1-40f7-b878-b216db5f325d	2026-02-10	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	A-S Medication Solutions	b88b0cbc-c883-4d17-8f46-0e5bddc57835	2026-02-10	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN
Gabapentin	GABAPENTIN	A-S Medication Solutions	3dbd447f-4791-4c62-86b4-6f7928862785	2026-02-10	Warnings, Adverse reactions	Name fallback brand name: Gabapentin generic name: GABAPENTIN

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 3 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
63304-627	Gabapentin	Gabapentin	Ranbaxy Pharmaceuticals Inc.	ANDA	Current
63304-628	Gabapentin	Gabapentin	Ranbaxy Pharmaceuticals Inc.	ANDA	Current
63304-629	Gabapentin	Gabapentin	Ranbaxy Pharmaceuticals Inc.	ANDA	Current